Investing Acceleration of RAD204 Phase 1 dose escalation trial by admin May 12, 2025 May 12, 2025 Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial Download the PDF here. This post appeared first on investingnews.com previous post Triumph Gold Discovers a New Silver and Gold Vein Showing at the Freegold Mountain Project, Yukon next post House GOP unveils Medicaid work requirements in Trump’s ‘big, beautiful bill’ You may also like Radiopharm Theranostics Receives IND approval from US FDA... July 28, 2025 Torex to Acquire Prime Mining in US$449 Million... July 29, 2025 Amended Announcement – Piedra Redonda Gas Project Assessment October 17, 2024 Top 5 Canadian Biotech Stocks in 2025 April 23, 2025 QXR Secures Option to Additional Prospective US Lithium... September 26, 2024 Red Metal Resources Announces Grant of Stock Options October 3, 2024 New High-Grade Gold Discovery at Golden Ridge, NE... July 20, 2024 Bitcoin Well Provides Update to the Bitcoin Super... November 14, 2024 Horne 5 Project Update March 26, 2025 Cannabis Market 2024 Year-End Review December 24, 2024